- 3
- 2
GM
Gilles Montavon
5
Documents
Identifiants chercheurs
- gilles-montavon
- 0000-0002-3049-0106
- IdRef : 149319711
Présentation
Publications
- 5
- 5
- 4
- 4
- 4
- 3
- 3
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
Investigation of alendronate-doped Apatitic Cements as a Potential Technology for the Prevention of Osteoporotic Hip Fractures: Critical Influence of the Drug Introduction Mode on the In Vitro Cement Properties.Acta Biomaterialia, 2011, 7, pp.759-770. ⟨10.1016/j.actbio.2010.09.017⟩
Article dans une revue
hal-00608513v1
|
|
Novel phosphate-phosphonate hybrid nanomaterials applied to biologyProgress in Solid State Chemistry, 2006, 34, pp.257-266
Article dans une revue
hal-00320894v1
|
Alendronate-doped Apatitic Cements as a Potential Technology for the Prevention of Osteoporotic Hip FracturesE-MRS spring meeting 2010, Jun 2010, Strasbourg, France
Communication dans un congrès
hal-00640846v1
|
|
Characterization of new injectable biomaterials containing bisphosphonates17th Interdisciplinary Research Conference on Biomaterials, Apr 2007, Oxford, United Kingdom. pp.1391-2
Communication dans un congrès
hal-00451324v1
|
|
Incorporation d'agents thérapeutiques sur des matrices phosphocalciquesJournées scientifiques SFC Bretagne Pays de la Loire – Batz sur Mer (F) – 23-25 Mai 2005, 2005, Batz sur Mer, France
Communication dans un congrès
hal-00079746v1
|